A peripheral blood biomarker for alzheimer's disease

Ended Project Grant Awarded Last action

Award ID
R43AG069523
Recipient
Awarding agency
Obligated
$1,462,369

Award facts

Assistance listing
93.866 Aging Research
Completion date
Funding
  • $1,106,594.00 Federal
  • $355,775.00 Non-federal
Place of performance
Buena Vista, CO 81211, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $355,775 $0
Amendment A peripheral blood biomarker for alzheimer's disease - DNA methylation is a central epigenetic process. All diseases have genetic and/or epigenetic foundations;… $355,775 $355,775
Original award $395,044 $0

Quick answers

Who received award R43AG069523?

R43AG069523 was awarded to Topogen, Inc. by National Institute on Aging (National Institutes of Health) on August 1, 2020.

How much is award R43AG069523 worth?

$1,462,369 has been obligated on R43AG069523: $1,106,594 in federal funding and $355,775 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award